Study summary · research use only
Inhibition of L-692,429-stimulated rat growth hormone release by a weak substance P antagonist: L-756,867
Plain-language summary
Paraphrased from the published abstract below — not a verdict on whether anything works.
In this rat study, the abstract reports that L-756,867 (H2N,D-Arg,Pro,Lys,Pro,D-Phe,Gln,D-Trp,Phe,D-Trp,Leu, Leu,NH2), a weak substance P antagonist, inhibited L-692,429-stimulated GH release from rat primary pituitary cells dose-dependently; at 50 nM it shifted the L-692,429 dose-response curve rightward about tenfold. Substance P (1 microM) had no effect on basal or L-692,429-stimulated GH release. In anesthetized rats, L-756,867 inhibited L-692,429- and growth hormone-releasing hexapeptide (GHRP-6)-stimulated GH secretion dose-dependently, with complete inhibition at an i.v. dose of 100 micrograms/kg, but no effect on GRF-induced secretion. D-Lys3-GHRP-6 had no effect even at 2 mg/kg. The authors interpret this as L-692,429 and GHRP-6 acting via a common receptor and signaling pathway distinct from substance P.
Abstract
H2N,D-Arg,Pro,Lys,Pro,D-Phe,Gln,D-Trp,Phe,D-Trp,Leu, Leu,NH2 (L-756,867), a weak substance P antagonist, inhibited L-692,429-stimulated GH release from rat primary pituitary cells in a dose-dependent manner. At a concentration of 50 nM, L-756,867 shifted the dose-response curve of L-692,429-induced GH release to the right by about tenfold. It also impaired the ability of L-692,429 to potentiate the effect of growth hormone-releasing factor (GRF) on GH release. Substance P (1 microM) had no effect on basal or L-692,429-stimulated GH release. When tested in anesthetized rats, L-756,867 inhibited L-692,429- and growth hormone-releasing hexapeptide- (GHRP-6)-stimulated GH secretion in a dose-dependent manner. Complete inhibition was observed at an i.v. dose of 100 micrograms/kg of L-756,867. However, at the same concentration, it had no effect on GRF-induced GH secretion D-Lys3-GHRP-6, a GHRP-6 antagonist, had no effect on GHRP-6 or L-692,429-induced GH secretion even at an i.v. dose of 2 mg/kg. These results indicate that L-692,429 and GHRP-6 stimulate GH release both in vitro and in vivo via a common receptor and signaling pathway which is different from that of substance P in spite of the fact that their effects are inhibited by a weak substance P antagonist.
pepmg summarizes the peer-reviewed literature and links to every source — it sells nothing, ships nothing, and gives no medical, dosing, or human-use guidance. Don't just trust this summary: follow the citation to its source and read it yourself. Research use only.